Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.83 -1.27 (-13.96%)
At close: Oct 1, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Invested Capital (2022 - 2024)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Invested Capital of $31.84 million in the quarter ended Dec 31, 2024, compared with $955,035 a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Invested Capital (2022 - 2024) Analysis & Trends

Starting with the quarter ended Dec 31, 2022, Eupraxia Pharmaceuticals' Invested Capital history includes 5 quarters.

  • Across earlier years, Invested Capital came in at $955,035 in the year ended Dec 31, 2023 (-87.0%) and $7.35 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Eupraxia Pharmaceuticals 363.60 Mn 362.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 31.84 Mn
Jun 30, 2024 13.36 Mn
Mar 31, 2024 18.15 Mn
Dec 31, 2023 955,035.00
Dec 31, 2022 7.35 Mn
API Access

Eupraxia Pharmaceuticals Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=EPRX&period=max&api_key=YOUR_API_KEY